These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis. Heimes B, Farecki ML, Bartels S, Barrelmann A, Gutfleisch M, Spital G, Lommatzsch A, Pauleikhoff D. Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607 [Abstract] [Full Text] [Related]
6. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study. Clemens CR, Wolf A, Alten F, Milojcic C, Heiduschka P, Eter N. Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038 [Abstract] [Full Text] [Related]
7. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ. Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593 [Abstract] [Full Text] [Related]
8. The factors associated with retinal pigment epithelium tear development in the early phase after treatment initiation for age-related macular degeneration. Shiose S, Notomi S, Hashimoto S, Nagata J, Fukuda Y, Kano K, Ishikawa K, Sonoda KH. Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3171-3180. PubMed ID: 38713397 [Abstract] [Full Text] [Related]
9. Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents. Nguyen CL, Gillies MC, Nguyen V, Daien V, Cohn A, Banerjee G, Arnold J, Fight Retinal Blindness! Study Group. Ophthalmology; 2019 May; 126(5):735-742. PubMed ID: 30529685 [Abstract] [Full Text] [Related]
12. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Cunningham ET, Feiner L, Chung C, Tuomi L, Ehrlich JS. Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935 [Abstract] [Full Text] [Related]
13. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [Abstract] [Full Text] [Related]
14. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK. Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314 [Abstract] [Full Text] [Related]
15. RANIBIZUMAB IN PIGMENT EPITHELIAL TEARS SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Prospective Study. Larsen PP, Oishi A, Bedar MS, Heymer PKR, Clemens CR, König S, Gutfleisch M, Pauleikhoff D, Eter N, Wolf A, Holz FG, Krohne TU. Retina; 2019 Dec; 39(12):2369-2377. PubMed ID: 30198967 [Abstract] [Full Text] [Related]
16. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309 [Abstract] [Full Text] [Related]
17. Sequential retinal pigment epithelium tears following intravitreal Ranibizumab injections for age-related macular degeneration. Venkatesh R, Agrawal R, Thomas S, Reddy NG, Gupta A, Yadav NK, Chhablani J. Eur J Ophthalmol; 2023 May; 33(3):NP100-NP104. PubMed ID: 35388732 [Abstract] [Full Text] [Related]